Maria S. Zharkova

Maria S. Zharkova

Auto-generated profile, based on publicly available information

Maria S. Zharkova

Institute of Biomedical Chemistry, Moscow, Russia

Research Focus & Metrics

Academic Career Length

22Years (2005-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
26 July 2013 in Electroanalysis
Verified
Journal Article
Closed access
PDF file
ESElena V. Suprun
Elena V. Suprun
MZMaria S. Zharkova
Maria S. Zharkova
GMGalina E. Morozevich
Galina E. Morozevich
AVAlexander V. Veselovsky
Alexander V. Veselovsky
VSVictoria V. Shumyantseva
Victoria V. Shumyantseva
AAAlexander I. Archakov
Alexander I. Archakov

1 October 2014 in Steroids
Verified
Journal Article
Closed access
AKAlexey Kuzikov
Alexey Kuzikov
NDNikita O. Dugin
Nikita O. Dugin
SSSergey V. Stulov
Sergey V. Stulov
DSDmitry S. Shcherbinin
Dmitry S. Shcherbinin
MZMaria S. Zharkova
Maria S. Zharkova
AMAlexander Y. Misharin
Alexander Y. Misharin

9 April 2014 in SAR and QSAR in Environmental Research
Verified
Journal Article
Closed access
AVAlexander Vladimirovich Veselovsky
Alexander Vladimirovich Veselovsky
MZM.S. Zharkova
M.S. Zharkova
Vladimir Vassilievich PoroikovVladimir Vassilievich Poroikov
Vladimir Vassilievich Poroikov
MNM.C. Nicklaus
M.C. Nicklaus
Protein–protein interactions (PPI) are involved in most of the essential processes that occur in organisms. In recent years, PPI have become the object of increasing attention in drug discovery, particularly for anti-HIV drugs. Although the use of combinations of existing drugs, termed highly active antiretroviral therapy (HAART), has revolutionized the treatment of HIV/AIDS, problems with these agents, such as the rapid emergence of drug-resistant HIV-1 mutants and serious adverse effects, have highlighted the need for further discovery of new drugs and new targets. Numerous investigations have shown that PPI play a key role in the virus’s life cycle and that blocking or modulating them has a significant therapeutic potential. Here we summarize the recent progress in computer-aided design of PPI inhibitors, mainly focusing on the selection of the drug targets (HIV enzymes and virus entry machinery) and the utilization of peptides and small molecules to prevent a variety of protein–protein interactions (viral–viral or viral–host) that play a vital role in the progression of HIV infection.

10 January 2018 in Scientific Reports
Verified
Journal Article
Open access
PDF file
EKElena V. Kugaevskaya
Elena V. Kugaevskaya
AVAlexander V. Veselovsky
Alexander V. Veselovsky
MIMaria I. Indeykina
Maria I. Indeykina
NSNina I. Solovyeva
Nina I. Solovyeva
MZMaria S. Zharkova
Maria S. Zharkova
SKSergey A. Kozin
Sergey A. Kozin
Alzheimer’s disease (AD) is a multifactorial neurodegenerative disorder. Amyloid-β (Aβ) aggregation is likely to be the major cause of AD. In contrast to humans and other mammals, that share the same Aβ sequence, rats and mice are invulnerable to AD-like neurodegenerative pathologies, and Aβ of these rodents (ratAβ) has three amino acid substitutions in the metal-binding domain 1-16 (MBD). Angiotensin-converting enzyme (ACE) cleaves Aβ-derived peptide substrates, however, there are contradictions concerning the localization of the cleavage sites within Aβ and the roles of each of the two ACE catalytically active domains in the hydrolysis. In the current study by using mass spectrometry and molecular modelling we have tested a set of peptides corresponding to MBDs of Aβ and ratAβ to get insights on the interactions between ACE and these Aβ species. It has been shown that the N-domain of ACE (N-ACE) acts as an arginine specific endopeptidase on the Aβ and ratAβ MBDs with C-amidated termini, thus assuming that full-length Aβ and ratAβ can be hydrolyzed by N-ACE in the same endopeptidase mode. Taken together with the recent data on the molecular mechanism of zinc-dependent oligomerization of Aβ, our results suggest a modulating role of N-ACE in AD pathogenesis.

1 January 2017 in Russian Journal of Electrochemistry
Verified
Journal Article
Closed access
PDF file
ESElena V. Suprun
Elena V. Suprun
MZM. S. Zharkova
M. S. Zharkova
AVA. V. Veselovsky
A. V. Veselovsky
AAA. I. Archakov
A. I. Archakov
VSV. V. Shumyantseva
V. V. Shumyantseva
The electrochemical oxidation of thrombin on the surface of carbon screen printed electrodes was studied. The electrochemical activity of thrombin was predicted, using bioinformation analysis, based on the data about the electrochemical properties of amino acids. The number of potentially electroactive amino acid residues, namely, tyrosine (Tyr), tryptophan (Trp), cysteine (Cys), histidine (His), methionine (Met), and cystine (Cys-Cys) located on the protein surface and orientated by their electroactive groups toward the electrode surface, i.e., accessible for electrochemical oxidation was calculated. The theoretical data were confirmed experimentally by cyclic and square-wave voltammetry. The available data on the protein structure allowed us to attribute the recorded electrochemical signals of thrombin oxidation to certain types of amino acid residue: the oxidation peak with a potential maximum at 0.7–0.8 V (vs. Ag/AgCl) was attributed to the oxidation of the Trp and Tyr residues; the wave in the range 1.0–1.2 V, to the oxidation of His; and the wave at 1.2–1.5 V, to the oxidation of Met and Cys-Cys. The electroanalysis based on the oxidation peak of the Tyr and Trp amino acid residues allowed to detect thrombin up to the concentration of 10–7 M. The suggested strategy for predicting the electrochemical activity can be used for investigating the properties of many other proteins and peptides and serve as a basis for their quantitative determination when developing various sensor and biosensor devices.

1 April 2015 in Biochemistry (Moscow), Supplement Series B: Biomedical Chemistry
Verified
Journal Article
Closed access
PDF file
SSS. V. Stulov
S. V. Stulov
NDN. O. Dugin
N. O. Dugin
MZM. S. Zharkova
M. S. Zharkova
DSD. S. Shcherbinin
D. S. Shcherbinin
AKAlexey Kuzikov
Alexey Kuzikov
AVAlexander Vladimirovich Veselovsky
Alexander Vladimirovich Veselovsky
In order to find novel inhibitors of 17α-hydroxylase-17,20-lyase (cytochrome P450 17A1, CYP17A1), a key enzyme of biosynthesis of androgens, molecular docking of six new oxazoline-containing...